Shorter TB treatment regimens should be safer as well

Most ongoing and planned TB therapeutic trials are focused on shortening the duration of treatment while giving less consideration to other aspects of TB care that are important to people with TB. Here we argue that other variables besides duration of TB treatment should also be considered when deve...

Descripción completa

Detalles Bibliográficos
Autores principales: Rucsineanu, O., Agbassi, P., Herrera, R., Low, M., McKenna, L., Stillo, J., Winarni, P., Acharya, A., Sari, A. H.
Formato: Online Artículo Texto
Lenguaje:English
Publicado: International Union Against Tuberculosis and Lung Disease 2023
Materias:
Original Articles
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10446660/
https://www.ncbi.nlm.nih.gov/pubmed/37736577
http://dx.doi.org/10.5588/pha.23.0026

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10446660/
https://www.ncbi.nlm.nih.gov/pubmed/37736577
http://dx.doi.org/10.5588/pha.23.0026

Ejemplares similares